Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuki Uchida

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
International Journal of Chronic Obstructive Pulmonary Disease|June 12, 2023
Inspiratory and Expiratory Computed Tomography Imaging Clusters Reflect Functional Characteristics in Chronic Obstructive Pulmonary DiseaseYumiko Matsuo, Emiko Ogawa, Yoko Tsunoda, et al.
Respiratory Medicine Case Reports|June 5, 2023
Autobullectomy with COVID-19 in a patient with chronic obstructive pulmonary diseaseShinya Yokoe, Daisuke Kinose, Yasumitsu Ueki, et al.
Radiation Oncology (London, England)|October 4, 2017
Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitisYasuki Uchida, Takuya Tsugawa, Sachiko Tanaka-Mizuno, et al.
Plos One|December 28, 2020
Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective studyYasuki Uchida, Takuya Tsugawa, Sachiko Tanaka-Mizuno, et al.
ERJ Open Research|February 27, 2024
Association of gut microbiome with COPD in Japanese male residents: the SESSA studySatoru Kawashima, Daisuke Kinose, Hisatomi Arima, et al.
Cancer Medicine|June 3, 2023
Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trialMasahiro Iwasaku, Junji Uchino, Kenji Chibana, et al.
The Oncologist|January 18, 2019
Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II TrialAkira Nakao, Osamu Hiranuma, Junji Uchino, et al.
Journal of Clinical Medicine|June 11, 2020
Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous TreatmentAkira Nakao, Osamu Hiranuma, Junji Uchino, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 7, 2023
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumoniaMahoko Ikeda, Shu Okugawa, Kosuke Kashiwabara, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of Chronic Obstructive Pulmonary Disease|June 12, 2023
Inspiratory and Expiratory Computed Tomography Imaging Clusters Reflect Functional Characteristics in Chronic Obstructive Pulmonary DiseaseYumiko Matsuo, Emiko Ogawa, Yoko Tsunoda, et al.
Respiratory Medicine Case Reports|June 5, 2023
Autobullectomy with COVID-19 in a patient with chronic obstructive pulmonary diseaseShinya Yokoe, Daisuke Kinose, Yasumitsu Ueki, et al.
Radiation Oncology (London, England)|October 4, 2017
Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitisYasuki Uchida, Takuya Tsugawa, Sachiko Tanaka-Mizuno, et al.
Plos One|December 28, 2020
Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective studyYasuki Uchida, Takuya Tsugawa, Sachiko Tanaka-Mizuno, et al.
ERJ Open Research|February 27, 2024
Association of gut microbiome with COPD in Japanese male residents: the SESSA studySatoru Kawashima, Daisuke Kinose, Hisatomi Arima, et al.
Cancer Medicine|June 3, 2023
Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trialMasahiro Iwasaku, Junji Uchino, Kenji Chibana, et al.
The Oncologist|January 18, 2019
Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II TrialAkira Nakao, Osamu Hiranuma, Junji Uchino, et al.
Journal of Clinical Medicine|June 11, 2020
Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous TreatmentAkira Nakao, Osamu Hiranuma, Junji Uchino, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 7, 2023
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumoniaMahoko Ikeda, Shu Okugawa, Kosuke Kashiwabara, et al.
Pageof 4